NewsRx

Search our medical news database

Medical Devices

Research and Markets report says Cordis Medical Device Company may be expanding

Published in Surgery Litigation and Law Weekly, February 2nd, 2007

Research and Markets announced the addition of Cordis Medical Device Company Intelligence Report from Espicom Business Intelligence to their offering.

Based in Miami Lakes, Florida, Johnson & Johnson's Cordis unit manufactures and markets products for interventional medicine, minimally invasive computer-based imaging and electrophysiology (EP). The company's products are marketed through four divisions: Cordis Cardiology for coronary applications, Cordis Endovascular for vascular disease, Biosense Webster for EP in cardiovascular procedures and Cordis Neurovascular which leverages the company's technology into applications for the brain, as follows:-

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook